RAC1 and breast neoplasm: (84) developed an endosomal pH-responsive nanoparticle that carried Rac1 siRNA along with cisplatin, which resulted in efficient delivery of Rac1 targeting oligonucleotides and cisplatin in breast tumors and showed promising synergistic antitumor effects.